Background I felt strongly about improving the services for end of life relatives staying for long periods with their loved ones. I wanted to find out what they felt was missing from our care, and how we could improve their time with us. Method I conducted a survey of twenty EOL relatives asking about their experience generally and what could be improved. I asked the questions in a safe place, questions around this are obviously of a sensitive nature and I wanted them to feel free to answer openly and honestly. Introduction This case report illustrates the effective use of a continuous subcutaneous infusion of baclofen to improve spasticity in a patient approaching end of life. Report The patient was a 56 year old lady with a diagnosis of motor neurone disease (spinal onset; 'definite' by the El Escorial research criteria). She was admitted to the hospice for end of life care. She was severely dysarthric. She had a flicker of movement in her left hand, but no movement in her limbs otherwise. She communicated by nodding or shaking her head. She did not have a percutaneous endoscopic gastrostomy (PEG) tube in situ, and she was too frail for consideration of same. At the time of admission, she was taking baclofen 10 mg po tds for spasticity.
As she weakened, she couldn't swallow her oral medications, necessitating discontinuation of her baclofen.
Three days later, she developed painful spasticity of her temporomandiibular joint muscles. She was very distressed by this symptom. It persisted over the following five days despite opioid analgesia and benzodiazepines. A literature review revealed a case report demonstrating the effective and well tolerated use of subcutaneous baclofen in a patient who could no longer take his medications via PEG.
A decision was made to commence a continuous subcutaneous infusion with bacofen 10 mg over 24 hours and NaCl as the diluent. The intrathecal formulation of baclofen was used.
The following day, the patient reported improvement in her spasticity, and she was able to open her mouth. The improvement was sustained over the following four days, and she experienced no skin reactions at the infusion site. At this time she could no longer communicate, and she was beginning to die. The baclofen was discontinued as she was no longer benefitting. Conclusion This case illustrates the effective and well-tolerated administration of baclofen via subcutaneous infusion. If appropriate, we may consider this route again. Aims Primary aim: Assess compliance with national standards for completion of death certificates within 1 working day.
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RETROSPECTIVE ANALYSIS OF THE TIMELINESS OF COMPLETION OF PAPERWORK AND COMMUNICATION TO GENERAL PRACTICE (GP) FOLLOWING DEATH
Secondary aim: Evaluate speed and form of communication of death to GP. Background It is understood that effective and prompt communication to GPs facilitates provision of bereavement support to relatives after a death. Delayed paperwork delays funeral arrangements and causes unnecessary distress to those bereaved. There is very little research on how timing of paperwork and communication to the GP impacts on bereavement. This audit forms the initial work to address these issues in greater depth. Methods Retrospective review of clinical notes in an acute cancer hospital between 1/12/15 and 31/3/16. Results 87 patients died during the audit period. Death certificates were completed within 1 working day for 91.9% (79/86) patients. 1 patient was referred for post mortem so was excluded here. GPs were informed of death via discharge summaries or telephone conversations. Overall it was documented that 78% (68/87) GPs were informed of the patient's death. Summaries were completed within 1 working day of death for 60.9% (53/87), 2 or more working days for 17.2% (15/87). For 21.8% (19/87), the summary was not completed. 20% (17/87) deaths were communicated by phone. Conclusion Overall, death certification was completed in a timely fashion. Discharge summaries were completed promptly for most, but 21.8% were never completed.
The discrepancy in communication with GPs highlights the need for interventions to ensure information is communicated promptly and effectively to facilitate ongoing bereavement support. This could be achieved with dedicated proformas,
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